Company Claims To Be First To Sell Contactless Bank Card Chips Implanted Into Humans

The ‘about’ section on Walletmor’s LinkedIn reads: “Walletmor is the first-ever company providing legitimate payment implants.”

Firstly, customers must download an app called iCard - which is a digital wallet that can be linked to the Walletmor implant - and set up an account.

Next, customers must activate their implant via the iCard app and add money to their account.

The final step is booking an appointment to have the implant installed at a medical aesthetics clinic.

The implant is injected on the outside of the hand or in the forearm, just above the wrist. It’s recommended not to have the implant injected on a location where you’d normally wear jewellery or a watch.

A warning on Walletmor’s site reads: “Injecting the Walletmor implant is relatively easy, however, we do not recommend performing the injection process on your own. 

“Not only every surgeon but also every piercer from your hometown is able to perform the installation process with the attached instruction.”

Walletmor decided to create payment implants because the company thinks that ‘in order to move forward and constantly evolve, we must live in symbiosis with technology’.

Walletmor has also published customer reviews on its site, with one person gushing: “I’m a technology enthusiast and I consider Walletmor the next step in the payments industry.

“I have no physical side effects and I tend to forget that I have an implant in my hand.”

The paper said that Paprota had been ‘repurposing’ chips from MuchBetter, a third party supplier associated with Mastercard. 

Both companies are said to have ‘pulled the plug’ on Walletmor after learning of its actions and UK customers have allegedly had their accounts shut down.

MailOnline also claimed that customers have now been left with ‘redundant’ chips implanted in their skin and their only option is to have them removed, although Walletmor ‘insists it’s looking at ways to reprogram the chips’.

Paprota told LADbible: “We are aware of unexpected changes in our British offer that took place after Brexit. 

“Even though the problem personally affects only two people from the UK, we are focused on finding a workable solution that will enable our customers from the UK to continue using implants. We believe, like our 600 ambassadors from around the world, that transhumanism and safe smart implants will be an obvious part of global development.”